The cyclin-dependent kinase inhibitor UCN-01 plus cisplatin in advanced solid tumors: A California cancer consortium phase I pharmacokinetic and molecular correlative trial

Primo N Lara, Philip Mack, Timothy Synold, Paul Frankel, Jeff Longmate, Paul H. Gumerlock, James H. Doroshow, David R Gandara

Research output: Contribution to journalArticlepeer-review

76 Scopus citations

Fingerprint

Dive into the research topics of 'The cyclin-dependent kinase inhibitor UCN-01 plus cisplatin in advanced solid tumors: A California cancer consortium phase I pharmacokinetic and molecular correlative trial'. Together they form a unique fingerprint.

Medicine & Life Sciences